daily GLP-1 formulations for sensitive patients
Media Contact: Mimi Carmody, [email protected] SOURCE American Diabetes Association
Compounded semaglutide is the cheapest GLP-1 overall , starting as low as $139/month through telehealth providers like Eden, MEDVi, and TrimRx
Experts predict that by 2030, oral GLP-1s could make up about half of the GLP-1 market , showing how important theyre becoming
By Application: T2DM dominates, Obesity growing fastest Type 2 Diabetes Mellitus maintained the dominant application position in the GLP-1 Receptor Agonist Market in 2025, driven by the large established prescriber base, comprehensive insurance coverage for diabetes indications, and the longer clinical history of GLP-1 therapy in diabetes management that has built physician comfort and treatment guideline endorsement